By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Viriom 

6605 Nancy Ridge Drive

San Diego  California  92121  U.S.A.
Phone: 7-495-995-4944 Fax: n/a


SEARCH JOBS

Viriom Inc. is a late clinical-stage company developing antivirals for HIV treatment and prevention. Viriom's main goal is to combat HIV resistance and radically broaden global access to HIV therapy by developing simplified yet effective treatments.

YEAR FOUNDED:

2009

LEADERSHIP:

CEO: Hua Bai

CMO: Robert Murphy

CSO: Vadim Bichko

CBO: Vladimir Kan

CFO: Ronald Demuth

CLINICAL TRIAL:

Please click here for clinical trial information.

FOLLOW VIRIOM:



Key Statistics


Email: viriom@viriom.com
Ownership: Private

Web Site: Viriom
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
Viriom Obtains First Market Approval Of Elsulfavirine (Elpida) For Treatment Of HIV-1 Infection In Russia 7/25/2017 10:14:10 AM
Viriom Reports Positive Findings In Phase IIb Study Of Elpida As Compared To Efavirenz In Combination With TDF/FTC At CROI 2017 2/17/2017 7:37:37 AM
Viriom Announces Collaboration With NIH On Zika And Other Major Viral Diseases 1/6/2017 8:28:54 AM
Viriom Announces Appointment Of New Scientific Advisory Board Member 10/24/2016 9:56:39 AM
Viriom Announces Receipt Of Funding From The Skolkovo Foundation, ChemRar And Torrey Pines Investment To Develop Elpida, A Novel Preventive And Long-Acting Treatment Of HIV/AIDS 5/11/2016 8:51:58 AM
Viriom Expands Global Licensing Agreement With Roche (RHHBY) For Innovative Compound Development For HIV Treatment 11/20/2013 10:44:47 AM
Viriom Selects ChemDiv, Inc. to Develop HIV Program 10/19/2009 12:05:08 PM
//-->